Avoid common mistakes on your manuscript.
Correction to: Cancer Immunology, Immunotherapy (2023) 72:409–425 https://doi.org/10.1007/s00262-022-03238-w
In the article by Chen et al. in the Feb 2023 issue of Cancer Immunology Immunotherapy (“Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer” [pages 409–425]), the images captured by the microscope of Fig. 3C were incorrect due to the mistaken images being inadvertently inserted during the assembly of Fig. 3. The panels of Fig. 3C have been updated with the correct data. These errors do not affect the results or conclusions of this article. The corrected Fig. 3 is reproduced below.
The authors would like to apologize for any inconvenience caused to the readers by these changes.
Reference
Chen J, Hu J, Gu L, Ji F, Zhang F, Zhang M, Li J, Chen Z, Jiang L, Zhang Y, Shi R, Ma L, Jia S, Zhang Y, Zhang Q, Liang J, Yao S, Hu Z, Guo Z (2023) Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer. Cancer Immunol Immunother 72(2):409–425. https://doi.org/10.1007/s00262-022-03238-w
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chen, J., Hu, J., Gu, L. et al. Correction to: Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer. Cancer Immunol Immunother 72, 3401–3403 (2023). https://doi.org/10.1007/s00262-023-03510-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-023-03510-7